期刊文献+

转化生长因子β_1在糖尿病大鼠心肌中的表达及福辛普利的干预 被引量:3

The expression of TGF-P, in myocardium of diabetic rats and the effect of fosinopril
下载PDF
导出
摘要 目的 研究转化生长因子β_1(TGF-β_1)在糖尿病大鼠心肌中的表达及福辛普利(Fosino-pril)的干预作用。方法 大鼠20只建立糖尿病模型后,随机分为福辛普利治疗组及糖尿病未治疗组,每组10只,用免疫组织化学法检测糖尿病大鼠心肌TGF-β_1的表达及用福辛普利治疗后的变化,并与正常组对照。结果 正常组心肌细胞胞浆内,TGF-β_1表达呈弱阳性反应;糖尿病未治疗组呈强阳性反应;福辛普利治疗组呈阳性反应。用图像分析仪计算其平均吸光度A值分别为0.009±0.004、0.198±0.007及0.104±0.005。未治疗组TGF-β_1的表达明显高于正常组及治疗组(P<0.01)。结论 TGF-β_1在糖尿病大鼠心肌中的表达明显增强,而福辛普利能在一定程度上抑制其表达从而可能延缓糖尿病性心肌病的病理学进展。 Objective To investigate the effect of fosinopril on transforming growth factor-β1 (TGF-β1) expression in myocardial tissue of streptozotocin(STZ)-induced diatetic rats. Methods A total of 30 SD rats were enrolled in the study, 10 of them were set as normal controls, others were created the model of diabetes by injecting STZ, and then equally divided into fosinopril group and untreated group. Myocardial TGF-ft was observed in all three groups after 5 weeks. Results The expression of TGF-fi, in myocardial tissue was weakly positive in normal group, strongly positive in untreated group and positive in fosinopriol treat group, with absorbance being 0. 009 ± 0. 004,0. 198 ±0. 007 and 0. 104 ± 0. 005,respectively. Conclusion Fosinopril may partly suppress the increased TGF-β1 expression in myocardial tissue of diatetic rats. It may decrease significantly the myocardial injury of diabetic rats.
出处 《中国糖尿病杂志》 CAS CSCD 2003年第2期122-124,共3页 Chinese Journal of Diabetes
关键词 转化生长因子Β1 糖尿病 大鼠 心肌 福辛普利 免疫组织化学 Diabetes Myocardium Fosinopril Transforming growth factor-β1
  • 相关文献

参考文献4

二级参考文献12

共引文献57

同被引文献27

  • 1丁丽颖,李玉宏.高糖对心肌细胞转化生长因子β_1分泌的影响及缬沙坦的干预作用[J].临床内科杂志,2005,22(3):204-206. 被引量:1
  • 2Sadoshima J,Izumo S.Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts.Critical role of the AT1 receptor subtype.Circ Res,1993,73:413-423..
  • 3Rekha Singh,Nahid Alavi,Ashok K.et al.Role of angiotensin II in glucose-induced inhibition of mesangital natrix degradation.Diabetes,1999,48:2066-2073..
  • 4Sun Y,Zhang J,Zhang JQ,et al.Local angiotensin II and transforming growth factor-beta1 in renal fibrosis of rats.Hypertension,2000,35:1078-1084..
  • 5Pinto YM,Philipp T,Engler S,et al.Reduction in left ventricular messenger RNA for transforming growth factor beta(1) attenuates left ventricular fibrosis and improves survival without lowering blood pressure in the hypertensive TGR(mRen2)27 Rat.Hypertension,2000,36:747-754..
  • 6Schannwell CM,Scheineppheim M,Perings S et al.Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy.Cardiology,2002;98(1~2):33~39
  • 7Azar ST,Salti I,Zantout MS et al.Alteration in plasma transforming growth factor beta in normoalhuinuric type 1 and type 2 diabetic patient.J Clin Endoerinol Metab,2002;85(12):4680~4681
  • 8Doi K,Sawada F,Toda G et al.Alteration of antioxidants during the progression of heart disease in streptozotocin-induced diabetic rats.Free Radie Res,2001;34(3):251~261
  • 9Yu Y,Ohmori K,Chen Y et al.Effects of pravastatin on progression of glucose intolerance and cardiovascular remodeling in a type Ⅱ diabetes model.J Am Coil Cardiol,2004;44(4):904~913
  • 10Zhou GH,Li C,Cai L et al.Advanced glycation endproducts induce connective tissue growth factor-mediated ronal fibrosis predominantly through transforming growth factor-β1independent pathway.Am J Pathol,2004;165(6):2033~2043

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部